EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany

Susanne Singer iD, Katherine J Taylor iD, Yara Maria Machlah iD, Tim Brandenburg iD, Kerstin Lorenz iD, Sabine Wächter iD, Klaus Kraywinkel iD, Markus Luster iD, Friederike Eilsberger iD

Endocrine · 04.05.2026 · 91 (1)

DOI: 10.1007/s12020-026-04643-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, online erschienen am 04.05.2026. Verfasst von Susanne Singer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Cancer Center Mecklenburg-Vorpommern (CCC-MV), University Medical Center Rostock, Department of Quality of Life, Rostock, Germany. susa…. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin Rostock.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Because anaplastic thyroid cancer (ATC) is a rare diagnosis, detailed epidemiological data are difficult to find in publicly accessible platforms. The aim of this study was to report current incidence and survival estimates for ATC in Germany and to analyse their trends over time.

Methods

Data from the population-based cancer registries in Germany were pooled. ATC was classified according to the International Classification of Diseases, 10th edition (ICD-10). Age-standardised incidence rates (per 100,000) for the years 2011 to 2022 were calculated. The relative survival was estimated using period analysis. Annual percentage changes (APC) in the incidence and survival trends over time were computed.

Findings

The number of new ATC cases diagnosed between 2011 and 2022 was 2127 (924 in men and 1203 in women). The current raw incidence is 0.19 in men and 0.22 in women. The age-standardised incidence in men changed slightly, but not significantly, during this period (APC − 2%, p = 0.126; recent rate 0.11) while it decreased in women (APC − 3%, p < 0.001; recent rate 0.10). The five-year relative survival ranged from 11% (2020–2022) to 15% (2017–2019) and decreased considerably with age. There were no differences in survival between men and women and no evidence for a change in survival over time.

Conclusion

About two persons per 1 million inhabitants are currently diagnosed with ATC per year. Over the past 12 years, there was a slight decrease in ATC incidence, especially in women, while survival remained largely unchanged during this period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsHumansGermanyIncidenceFemaleMalePrevalenceAgedMiddle AgedRegistriesAged, 80 and overAdultSurvival Rate

Stichwörter der Autor:innen

AnaplasticIncidenceMortalityOccurrenceRiskSurvivalThyroid Carcinoma

Autor:innen und Institutionen

  • Comprehensive Cancer Center Mecklenburg-Vorpommern (CCC-MV), University Medical Center Rostock, Department of Quality of Life, Rostock, Germany. susanne.singer@uni-rostock.de.
  • Comprehensive Cancer Center Mecklenburg-Vorpommern (CCC-MV), University Medical Center Rostock, Department of Quality of Life, Rostock, Germany.
  • University Hospital Essen, Department of Endocrinology, Diabetology & Metabolism, Essen, Germany.
  • West German Cancer Center, Essen, Germany.
  • Martin Luther University Halle Wittenberg, Medical Faculty, Department of Visceral, Vascular & Endocrine Surgery, Halle, Saale, Germany.
  • Philipps University Marburg, University Hospital of Giessen & Marburg, Department of Visceral Thorax and Vascular Surgery, Marburg, Germany.

ORCID-Profile: Susanne Singer, Katherine J Taylor, Yara Maria Machlah, Tim Brandenburg, Kerstin Lorenz, Sabine Wächter, Klaus Kraywinkel, Markus Luster, Friederike Eilsberger

Förderung

  • Universitätsmedizin Rostock

Zitieren

APA

Singer, S., Taylor, K. J., Machlah, Y. M., Brandenburg, T., Lorenz, K., Wächter, S., Kraywinkel, K., Luster, M., & Eilsberger, F. (2026). Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany. Endocrine, 91(1). https://doi.org/10.1007/s12020-026-04643-2

Vancouver

Singer S, Taylor KJ, Machlah YM, Brandenburg T, Lorenz K, Wächter S, et al. Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany. Endocrine. 2026;91(1). doi:10.1007/s12020-026-04643-2

BibTeX
@article{Singer2026,
  author = {Singer, Susanne and Taylor, Katherine J and Machlah, Yara Maria and Brandenburg, Tim and Lorenz, Kerstin and Wächter, Sabine and Kraywinkel, Klaus and Luster, Markus and Eilsberger, Friederike},
  title = {Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany},
  journal = {Endocrine},
  year = {2026},
  volume = {91},
  number = {1},
  doi = {10.1007/s12020-026-04643-2}
}
Kostenlos starten →